atherosclerosis/protease

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

Bls 1 frá 22 niðurstöður

Cardiac Injury in COVID-19: a Pathology Study

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Since Dec 2019, coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has resulted in considerable morbidity and mortality throughout the world. On April 21 2020, Italy and US have registered over 187,000 and 855,000 cases of confirmed COVID-19

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

EXISTING KNOWLEDGE AND MAIN ASSUMPTIONS OF THE PROJECT. Atherosclerosis is the most common cause of peripheral artery disease (PAD). The first symptom of PAD is intermittent claudication (IC), which is characterized by the occurrence of pain, cramps, numbness, and discomfort in the lower limb

How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: A Serial CT Study

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects)

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Lysosomal acid lipase (LAL) is encoded by LIPA gene located on chromosome 10q23.3-q23 and consists of 10 exons. LIPA mRNA (messenger RiboNucleic Acid) (GenBank accession number NM_000235) is 2782 bp long and encodes a mature protein of 375 residues (GenBank accession number NP_000226). The

Predicting Pancreatic Necrosis Using mitDNA

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Acute pancreatitis (AP) is inflammation of the pancreas that can become a fatal disease or lead to severe complications . It is characterized clinically by abdominal pain and by increased pancreatic enzyme levels in the blood or urine. Gallstone migration and alcohol abuse are the two major risk

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Cardiovascular disease (CVD) due to atherosclerosis continues to be the leading single cause of death in industrialized countries. High serum lipid levels, and especially high low-density lipoprotein cholesterol (LDL-C) levels, have been demonstrated to strongly and directly correlate with CVD risks

Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Physicians in charge of HIV-infected patients are increasingly being faced to previously unrecognized comorbid conditions such as atherosclerosis and cardiovascular events, loss of renal function, osteopenia/osteoporosis and bone fractures or non-AIDS-defining cancers (1-4). The incidence of these

Bococizumab HIV Evaluation (B-HIVE) Study

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Rationale: Cardiovascular disease (CVD) has emerged as a leading cause of morbidity and mortality in HIV-infected individuals. The precise mechanisms underlying this increased cardiovascular risk remain to be elucidated . Platelet hyperreactivity and increased platelet-monocyte aggregation (PMA) are

IPHAAB-study Influence of Physical Activity on Atherosclerosis Biomarkers

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

According to Statistik Austria, cardiovascular disease (CVD) is the most common reason for death in Austria in total population. In 2011, 42,3 % of all deaths were due to CVD (ICD-10 I00-I99). In People aged 45-64 years, CVD is, beyond cancer, the second most common cause of death. According to the

IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Background Coronary atherosclerosis is responsible for the initiation of acute myocardial infarction with plaque rupture leading to acute coronary thrombosis and myocardial infarction. Current treatment in the acute phase involves re-establishing vessel patency by percutaneous coronary intervention

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Why is this clinical problem important? Peripheral Arterial Disease (PAD) is a major health problem in Australia, with a prevalence of 15% in males aged over 65 years. The direct health care cost of PAD in Australia was $180m in 1994, of which 78% was associated with hospitalisations. PAD is also a

Saxagliptin and Atherosclerosis

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

RAltegravir Switch STudy: Effects on Endothelial Recovery

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Fixed dose combination lopinavir/ritonavir (LPV/r) is a widespread used antiretroviral drug belonging to the class of protease inhibitors (PIs). PIs are associated with an increased risk of myocardial infarction. However, data is available suggesting increased levels of plasma lipids are not the

Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Low high density lipoprotein (HDL) and a lipid pattern consistent with atherogenic dyslipidemia are also common in the human immunodeficiency virus (HIV)infected population and is likely due, in large part, to the chronic inflammatory effect of HIV infection per se. While highly active

Fyrri
1
2
Næst

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum